Dicaris Adults 150 mg (Levamisole)

Dicaris Adults 150 mg (Levamisole) — Complete Pharmacy Guide

What is Dicaris Adults 150 mg?

When it comes to treating intestinal worm infections quickly, effectively, and with the convenience of a single dose, Dicaris Adults 150 mg stands as one of the most straightforward and reliable options available in the human pharmacy setting. A well-established brand name in antiparasitic medicine, Dicaris Adults contains 150 mg of Levamisole hydrochloride — a dose specifically calibrated for adult patients and designed to deliver fast, effective treatment against the most common intestinal nematode infections affecting adults worldwide.

Dicaris is manufactured by Janssen Pharmaceutica — a subsidiary of Johnson & Johnson — and has been a trusted name in human antiparasitic therapy for decades. Its reputation rests on a combination of proven clinical efficacy, a well-characterized safety profile at the single therapeutic dose used in human medicine, and the practical simplicity of single-dose oral treatment — a significant advantage in terms of patient compliance compared to multi-day treatment regimens.

Levamisole — the active pharmaceutical ingredient in Dicaris Adults 150 mg — is a member of the imidazothiazole class of anthelmintic compounds. First synthesized in 1966 by scientists at Janssen Pharmaceutica, it was originally developed as a veterinary dewormer before its potential in human medicine was recognized and developed. Over the following decades, Levamisole earned a dual identity in the pharmaceutical world — firstly as an antiparasitic agent, and secondly as a biological response modifier with immunostimulatory properties that attracted significant interest in oncology and immunology research.

In the context of Dicaris Adults 150 mg — the human medicine formulation — it is the antiparasitic application that is the primary clinical focus. At the 150 mg single-dose level used in adult human therapy, Levamisole delivers targeted, rapid-acting treatment against specific intestinal worm infections, backed by decades of clinical use across diverse global patient populations.

What makes Dicaris Adults 150 mg particularly relevant in today’s pharmacy landscape is its continued importance in regions of the world where intestinal parasitic infections remain highly prevalent — tropical and subtropical countries across Asia, Africa, and Latin America where inadequate sanitation, limited access to clean water, and high population density create conditions in which parasitic worm infections spread readily and affect communities at scale. In these settings, Dicaris Adults 150 mg represents an accessible, affordable, and clinically proven treatment option that pharmacists and healthcare workers can confidently recommend.

The Pharmacology of Levamisole — How Dicaris Adults Works?

To truly appreciate why Dicaris Adults 150 mg works so rapidly and effectively, it is worth understanding the precise mechanism through which Levamisole acts on parasitic organisms — and why this mechanism is so pharmacologically valuable.

Nicotinic Acetylcholine Receptor Agonism — Spastic Paralysis

The human nervous system — like that of all animals — relies on neurotransmitters to carry signals between nerve cells and from nerves to muscles. One of the most important of these neurotransmitters is acetylcholine, which acts at nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction — the point where motor nerves meet muscle fibers. Under normal physiological conditions, acetylcholine is released, briefly stimulates the receptor to trigger muscle contraction, and is then rapidly broken down by the enzyme acetylcholinesterase, allowing the muscle to relax and the cycle of contraction and relaxation to continue in a coordinated, rhythmic fashion.

Levamisole acts as a potent and sustained agonist at the specific subtype of nicotinic acetylcholine receptors found in parasitic nematode neuromuscular junctions. By binding to these receptors and continuously stimulating them — without being broken down the way acetylcholine is — Levamisole produces sustained, irreversible depolarization of the parasite’s muscle cells. The result is spastic paralysis — the worm’s entire musculature locks into a state of continuous rigid contraction from which it cannot recover.

This spastic paralysis has two critical consequences for the parasite:

• The worm loses its ability to maintain its grip on the intestinal wall and sustain its position in the gastrointestinal tract
• Normal intestinal peristalsis — the wave-like muscular contractions that move contents through the bowel — sweeps the paralyzed, helpless worm along and expels it from the body in the faeces

This process happens rapidly — within hours of taking Dicaris Adults 150 mg — which is why Levamisole is appreciated for its fast onset of action compared to some other antiparasitic agents.

Why Levamisole Is Selective — And Why the Margin Matters?

The pharmacological selectivity of Levamisole rests on the fact that the specific nAChR subtypes found at nematode neuromuscular junctions are pharmacologically and structurally distinct from those found in human skeletal muscle and autonomic nervous system. At the 150 mg therapeutic dose used in Dicaris Adults, Levamisole acts predominantly on the parasite’s receptors while largely sparing the human host’s neuromuscular function.

However — and this is a distinction that pharmacists should always communicate clearly to patients — this selectivity is less absolute than that of benzimidazoles. The safety margin, while adequate at the correct therapeutic dose, is narrower than that of drugs like Albendazole or Mebendazole. This is one of the reasons why the 150 mg dose for adults should not be exceeded and why Dicaris Adults 150 mg is specifically formulated and indicated for adults — not children, for whom separate weight-appropriate dosage forms exist.

Immunomodulatory Properties — The Bonus Mechanism

Beyond its antiparasitic action, Levamisole possesses a pharmacologically fascinating secondary property — the ability to act as a biological response modifier that stimulates and regulates the host immune system. At therapeutic doses, Levamisole has been shown to:

• Restore and enhance T-lymphocyte function — particularly in immunocompromised or immunosuppressed states
• Stimulate macrophage activity — improving phagocytosis and antigen presentation
• Enhance natural killer (NK) cell cytotoxicity
• Improve neutrophil chemotaxis — the ability of neutrophils to migrate toward infection sites

These immunostimulatory properties are the basis for Levamisole’s historical use as an adjunct in cancer chemotherapy and its ongoing use in certain immunological conditions. While these effects are not the primary reason a patient receives Dicaris Adults 150 mg for a worm infection, they represent an interesting additional dimension of the drug’s pharmacological profile that distinguishes it from purely antiparasitic agents.

What Conditions Does Dicaris Adults 150 mg Treat?

Primary Antiparasitic Indications

Ascariasis — Roundworm Infection (Ascaris lumbricoides): This is the primary and most important indication for Dicaris Adults 150 mg in human medicine. Ascaris lumbricoides is the largest and most prevalent intestinal nematode affecting humans globally — it is estimated that over 800 million people are infected worldwide, with the highest burden in tropical and subtropical regions with poor sanitation. The adult worms — which can grow up to 35 cm in length — live in the small intestine, where they compete with the host for nutrients, cause abdominal discomfort, and in heavy infections can cause intestinal obstruction, biliary colic, and pancreatitis when worms migrate into the bile ducts or pancreatic duct.

Dicaris Adults 150 mg delivers a single-dose treatment that is highly effective against adult Ascaris worms, causing rapid spastic paralysis and expulsion of worms in the faeces — typically within 24 hours of treatment.

Hookworm Infections (Ancylostoma duodenale and Necator americanus): Hookworms are blood-feeding intestinal nematodes that attach to the wall of the small intestine and feed on host blood — each worm consuming a small but significant volume of blood daily. Heavy hookworm burdens cause iron-deficiency anaemia, protein malnutrition, fatigue, and impaired physical and cognitive development — particularly devastating in children, pregnant women, and individuals with already marginal nutritional status.

Ancylostoma duodenale — the Old World hookworm — is the species more commonly encountered in South Asia, the Middle East, and the Mediterranean. Levamisole is effective against both hookworm species, though a repeat dose or multi-day course may be more appropriate for heavy hookworm burdens.

Enterobiasis — Pinworm (Enterobius vermicularis): Pinworm is the most common helminth infection in developed countries and is highly prevalent in school-age children and the adults living in close contact with them. The characteristic symptom is intense perianal itching — particularly at night — caused by female worms migrating to the perianal skin to lay eggs. A single dose of Dicaris Adults 150 mg is effective against adult pinworms. Because pinworm reinfection is extremely common due to the environmental persistence of eggs and the ease of faecal-oral transmission, a repeat dose after 2 weeks is routinely recommended, along with strict household hygiene measures and simultaneous treatment of all household members.

Trichuriasis — Whipworm (Trichuris trichiura): Levamisole has some activity against whipworm, though its efficacy as monotherapy for Trichuris is generally considered less reliable than for Ascaris or hookworm. For significant whipworm infections, Albendazole or Mebendazole are typically preferred as first-line agents, and Levamisole may be used as part of combination therapy.

Dosage and Administration:-

Adult Dose for Antiparasitic Indications:

How to Take Dicaris Adults 150 mg:

• Take the tablet orally with a full glass of water
• May be taken with or without food — taking it with a light meal may reduce the incidence of nausea or stomach discomfort in sensitive patients
• Swallow the tablet whole — do not crush or chew unless specifically directed
• For the best results, take at the same time each day if a multi-day course is prescribed
• Do not take a double dose if you miss one — skip the missed dose and continue with your regular schedule

Important Dosing Note: Dicaris Adults 150 mg is specifically formulated for adults and adolescents above 15 years of age or those weighing more than 45–50 kg. For children, separate pediatric formulations of Levamisole with appropriate lower dosing are available. Do not give Dicaris Adults tablets to children without explicit medical guidance — the dose would need to be carefully adjusted by body weight.

Drug Interactions:-

Warfarin and Anticoagulants: Levamisole may potentiate the anticoagulant effect of Warfarin, increasing the risk of bleeding. Patients on anticoagulant therapy should have their INR monitored more closely during and after Levamisole treatment. Inform your doctor or pharmacist if you are taking any blood-thinning medication.

Phenytoin: Levamisole may increase plasma concentrations of Phenytoin by inhibiting its hepatic metabolism. Patients with epilepsy taking Phenytoin should be monitored for signs of Phenytoin toxicity — including nystagmus, ataxia, and confusion — during concurrent Levamisole use.

Alcohol: A disulfiram-like reaction has been reported when Levamisole is taken concurrently with alcohol — characterized by flushing, nausea, vomiting, palpitations, and headache. Patients should be advised to avoid alcohol on the day of treatment and for at least 24 hours after taking Dicaris Adults 150 mg.

Fluorouracil (5-FU): When used in oncology protocols in combination with 5-FU, Levamisole enhances the toxicity of 5-FU — a combination that requires careful oncological supervision and monitoring for enhanced adverse effects, including mucositis and leucopenia.

Immunosuppressive Agents: Levamisole’s immunostimulatory activity may theoretically counteract the effects of immunosuppressive drugs such as corticosteroids, cyclosporine, or azathioprine. This interaction requires specialist evaluation before concurrent use.

Pyrantel and Morantel (Veterinary Context): While not applicable to human patients, it is worth noting for completeness that concurrent use of Levamisole with other nicotinic receptor agonists like Pyrantel produces additive cholinergic toxicity — an important consideration in veterinary settings.

Side Effects:-

At the 150 mg Single Dose — Generally Well Tolerated: The vast majority of adult patients taking a single 150 mg dose of Dicaris Adults for intestinal worm treatment experience no significant side effects. When side effects do occur at this dose, they are typically mild and brief:

• Nausea or mild stomach discomfort — most common; usually resolves within a few hours
• Dizziness or lightheadedness
• Headache
• Metallic or bitter taste in the mouth
• Mild skin rash or itching
• Loose stools or mild diarrhoea

Storage Instructions:-

• Store at room temperature between 15°C and 30°C (59°F–86°F)
• Protect from direct sunlight, heat, and moisture
• Store in the original blister packaging until ready to take
• Do not store in the bathroom — humidity accelerates tablet degradation
• Keep out of reach of children at all times
• Do not use beyond the expiry date printed on the packaging
• Return any unused or expired tablets to your pharmacy for safe disposal — do not discard in household waste or flush down the toilet

Frequently Asked Questions (FAQs)?

Q1. Can I buy Dicaris Adults 150 mg without a prescription?

The dispensing status of Dicaris Adults 150 mg varies by country. In some countries and regions, it is available over the counter for the treatment of common intestinal worm infections; in others, it requires a prescription. Regardless of its regulatory status in your location, it is always advisable to have a proper diagnosis confirmed before treatment and to consult a pharmacist or doctor if you have any questions about whether this is the right medicine for your situation.

Q2. How quickly will I see results after taking Dicaris Adults 150 mg?

Levamisole acts rapidly — spastic paralysis of susceptible worms begins within a few hours of ingestion. Most adult worms are expelled from the intestinal tract within 24 hours of taking the tablet. You may notice dead or dying worms passing in your stool during this period — this is completely normal and confirms the medicine is working. If you do not notice any improvement within 48–72 hours, consult your doctor or pharmacist.

Q3. Do I need to take a laxative or special diet alongside Dicaris Adults?

No — no special dietary preparation, fasting, or laxative is required with Dicaris Adults 150 mg. The medicine works effectively on its own. The paralyzed worms are expelled naturally by normal bowel movements. Simply take the tablet as directed with a glass of water.

Q4. Is Dicaris Adults 150 mg safe to take if I am on blood thinners?

This requires careful attention. Levamisole can enhance the anticoagulant effect of Warfarin and similar blood-thinning medicines, potentially increasing the risk of bleeding. If you are taking Warfarin or any other anticoagulant, you must inform your doctor and pharmacist before taking Dicaris Adults 150 mg. Your INR may need to be monitored more closely around the time of treatment.

Q5. Can I drink alcohol after taking Dicaris Adults 150 mg?

It is strongly advised to avoid alcohol on the day of treatment and for at least 24 hours afterward. A disulfiram-like reaction — characterized by facial flushing, nausea, vomiting, and palpitations — has been reported when Levamisole and alcohol are taken together. This reaction, while not typically dangerous in healthy individuals, is very uncomfortable and entirely avoidable by simply abstaining from alcohol around the time of treatment.

Q6. My child also has worms — can they take Dicaris Adults 150 mg?

No — Dicaris Adults 150 mg is specifically formulated for adults and should not be given to children. The 150 mg dose is too high for children, who require weight-based dosing with an appropriate pediatric formulation of Levamisole or an alternative antiparasitic medicine such as Mebendazole suspension or Albendazole. Consult your pharmacist or doctor for the appropriate product and dose for your child’s age and weight.

⚠️ Disclaimer:-

The information provided in this comprehensive guide about Dicaris Adults 150 mg (Levamisole) is intended strictly for general educational and informational purposes only and does not constitute medical advice, a clinical diagnosis, or a personalized treatment recommendation for any individual patient or health condition. This content must not replace consultation with a qualified and licensed medical doctor, pharmacist, or registered healthcare professional who is familiar with your individual health status, medical history, current medications, and specific clinical circumstances.